FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

DoJ Using Healthcare Data for Marketing Cases

[ Price : $8.95]

Principal deputy assistant attorney general Benjamin Mizer says the department is making greater use of healthcare data in its sal...

Insightec Files PMA for Exablate Neuro

[ Price : $8.95]

Insightec files a PMA for the Exablate Neuro focused ultrasound ablation device for treating essential tremor.

FDA Safety Alert on AbbVie Hepatitis C Drugs

[ Price : $8.95]

FDA warns that hepatitis C treatments Viekira Pak and Technivie, both made by AbbVie, can cause serious liver injury in patients w...

Donnelly Touts Medical Innovation Agenda

[ Price : $8.95]

Sen. Joe Donnelly says he is backing a number of bills in what he calls a Medical Innovation Agenda.

Authors Defend 21st Century Cures Concerns

[ Price : $8.95]

Authors Aaron Kesselheim and Jerry Avorn respond to critics of some of their criticisms of the 21st Century Cures Act.

FDA Orders New Studies on Concordias Kayexalate

[ Price : $8.95]

FDA orders Concordia Pharmaceuticals to conduct postmarketing studies to investigate Kayexalates (sodium polystyrene sulfonate) po...

Two Groups Back Pacira Free Speech Bid

[ Price : $8.95]

Two drug industry trade groups tell a New York federal court they support Paciras efforts to make truthful and non-misleading stat...

FDA Awards Contract to Study Milled Opioid Bioavailability

[ Price : $8.95]

FDA awards a contract to Vince & Associates Clinical Research to conduct a clinical pharmacology pharmacokinetic study of opioids ...

Biogen Tysabri Misses Endpoints in MS Study

[ Price : $8.95]

Biogen says its Phase 3 ASCEND study investigating Tysabri (natalizumab) in treating secondary progressive multiple sclerosis did ...

Prize Competition to Further Open Science

[ Price : $8.95]

The National Institutes of Health announces a global competition to find new products or services to advance open science.